Clinical Trial

The Effectiveness of Health Education Intervention in Enhancing Personal Protective Equipment Use

Completed
View on ClinicalTrials.gov →
Summary
This study is testing whether a health education program can help commercial motorcycle riders and passengers in the Limbe and Tiko Health Districts of Cameroon improve their use of safety equipment. These include items like helmets, reflective jackets, and other materials that help riders and passengers be more visible and protected on the road. People who ride or travel on motorcycles are at high risk for road injuries, especially when visibility is low. Wearing personal protective equipment (PPE) and visibility materials can prevent many of these injuries, but many riders do not use them regularly. The study involves educating riders and passengers through group sessions and follow-up messages about the importance of safety gear. The investigators will compare the use of PPE and visibility materials before and after the health education intervention to see if it made a difference. Adults aged 18 and older who ride or travel on motorcycles in Limbe or Tiko are eligible to participate. The study will last several months and does not involve any drugs or medical procedures. There is no known risk to participants. The results will help guide future road safety programs in Cameroon and other similar settings
Protocol Amendment History 3 changes
critical Trial completed 2026-07-25
notable Primary completion pushed: 2025-08-30 -> 2025-11-30 2026-07-25
minor Completion pushed: 2025-09-20 -> 2026-03-15 2026-07-25
Trial Details
NCT Number NCT07087444
Lead Sponsor University of Buea
Collaborators: University of California, Los Angeles, University of California, Berkeley, Fogarty International Center of the National Institute of Health
Conditions Road Traffic Injury Prevention, Motorcycle Safety, Personal Protective Equipment Use, Visibility Materials, Injury Prevention Education, Health Behavior Change
Enrollment 967 participants
Start Date 2024-05-15
Primary Completion 2025-11-30 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-24